NPPNY (NPPNY) Stock Price & Analysis
NPPNY (NPPNY) rose 6.56% to USD 6.5 as of June 10, 2026 at 02:40 UTC, according to Nexqual real-time market data.
NPPNY last closed at USD 6.1; the session ranged USD 6.5–6.5 on volume of 420 shares. Market capitalization is $1.75B, with a 52-week range of USD 5.03–15.21 (PNK). Source: Nexqual, June 10, 2026 at 02:40 UTC.
Key Statistics (as of June 10, 2026 at 02:40 UTC)
| Price | USD 6.5 |
|---|---|
| Change | ▲ 6.56% (up) |
| Previous Close | USD 6.1 |
| Open | USD 6.5 |
| Day Range | USD 6.5 – 6.5 |
| 52-Week Range | USD 5.03 – 15.21 |
| Volume | 420 shares |
| Market Cap | $1.75B |
| Exchange | PNK |
Technical Analysis (NPPNY)
Nexqual's technical model rates NPPNY "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:40 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 7.48) |
| MACD | -0.51 (negative) |
Analyst Ratings (NPPNY)
Wall Street analysts rate NPPNY "None", per Nexqual as of June 10, 2026 at 02:40 UTC.
| Consensus Rating | None |
|---|
Earnings (NPPNY)
| Revenue Estimate | $47.75B |
|---|
Source: Nexqual, June 10, 2026 at 02:40 UTC.
Financials & Fundamentals (NPPNY)
| Total Revenue | $170.77B |
|---|---|
| Revenue Growth (YoY) | +12.10% |
| Gross Margin | +66.35% |
| Operating Margin | +7.25% |
| Profit Margin | +17.40% |
| ROE | +11.03% |
| Debt / Equity | 0.88 |
| Current Ratio | 4.35 |
| Total Cash | $76.59B |
| Total Debt | $2.57B |
| Free Cash Flow | $25.16B |
Source: Nexqual, June 10, 2026 at 02:40 UTC.
Financial Health Score (NPPNY)
Nexqual rates NPPNY's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:40 UTC.
| Growth | Solid — Revenue +7% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 66%, operating 7% |
| Balance Sheet | Strong — $76.6B cash vs $2.57B debt, net cash position |
| Cash Flow | Solid — FCF $25.2B, 15% margin |
| Efficiency | Mixed — ROE 11%, ROA 7.0% |
Ownership (NPPNY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.02% |
| Shares Outstanding | 269.60M |
| Float | 250.93M |
Source: Nexqual, June 10, 2026 at 02:40 UTC.
Leadership (NPPNY)
NPPNY is led by Toru Nakai (age 54), President & Director, per Nexqual as of June 10, 2026 at 02:40 UTC.
| President & Director | Toru Nakai (age 54) |
|---|---|
| Director of Sales and Marketing & Director | Kazuyuki Iwata (age 59) |
| GM of Personnel, General Affairs, Risk Mgmt, Compliance & Digital Trans and Director | Takashi Takaya (age 65) |
| Head of Business Management & Sustainability and Director | Takanori Edamitsu (age 62) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NHNKY | Nihon Kohden Corp. | USD 8.75 | ▲ 0.29% |
| SNPHY | Santen Pharmaceutical Co., Ltd. | USD 12.2 | ▲ 3.83% |
| SGIOY | Shionogi & Co. Ltd. | USD 8.56 | ▼ 2.28% |
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
| IPSEY | Ipsen S.A. | USD 42.27 | ▼ 6.15% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:40 UTC. This page is informational and not investment advice.